Endocrinology and Diabetes Unit, Hospital Universitari de Bellvitge, c/ Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.
Endocrine. 2010 Oct;38(2):235-42. doi: 10.1007/s12020-010-9379-4. Epub 2010 Jul 23.
To analyse in a cohort of healthy subjects and in a group of morbidly obese patients, we studied the association amongst 25(OH) D and plasma concentrations of adipocytokines, inflammatory cytokines and insulin resistance. We also aimed to determine whether vitamin D-deficient patients showed a greater inflammatory profile. In the observational study that the authors conducted, plasma concentrations of 25(OH) D, leptin, resistin, adiponectin and interleukine-18 were determined in 134 healthy men and 127 women. In the population consisting of 44 patients with morbid obesity, plasma concentrations of 25(OH) D, leptin, resistin, adiponectin, interleukine-18, soluble tumor necrosis factor receptors 1 and 2 and C-reactive protein were analysed. In the healthy population, plasma 25(OH) D showed a negative correlation with body mass index, body fat, waist, hip circumference and with leptin. However, no significant associations were found amongst 25(OH) D and plasma concentrations of resistin, adiponectin or interleukine-18. Patients with vitamin D deficiency showed higher body mass index, fat mass percentage and higher leptin concentrations compared with subjects with normal 25(OH) D concentrations. In the morbidly obese subjects, 25(OH) D did not correlate with leptin, resistin, adiponectin, interleukine-18, soluble tumor necrosis factor receptors 1 and 2 or with C-reactive protein. In patients with morbid obesity, no differences were found in adipokines and inflammatory cytokines concentrations regarding 25(OH) D status. No associations were found either between 25(OH) D and plasma glucose and insulin resistance or with lipid profile. Plasma 25(OH) D concentrations are associated with adiposity markers but not with adipocytokines implicated in inflammation. This lack of association does not support a major role of 25(OH) D in the pro-inflammatory environment observed in morbidly obese subjects. In addition, subjects with vitamin D deficiency are not characterized by a greater inflammatory state.
在一项健康受试者队列和一组病态肥胖患者中,我们研究了 25(OH)D 与血浆脂肪细胞因子、炎症细胞因子和胰岛素抵抗之间的关联。我们还旨在确定维生素 D 缺乏症患者是否表现出更大的炎症特征。在作者进行的观察性研究中,测定了 134 名健康男性和 127 名健康女性的血浆 25(OH)D、瘦素、抵抗素、脂联素和白细胞介素-18 浓度。在由 44 例病态肥胖患者组成的人群中,分析了血浆 25(OH)D、瘦素、抵抗素、脂联素、白细胞介素-18、可溶性肿瘤坏死因子受体 1 和 2 以及 C-反应蛋白的浓度。在健康人群中,血浆 25(OH)D 与体重指数、体脂肪、腰围、臀围和瘦素呈负相关。然而,25(OH)D 与抵抗素、脂联素或白细胞介素-18 之间未发现显著相关性。与 25(OH)D 浓度正常的受试者相比,维生素 D 缺乏症患者的体重指数、体脂肪百分比和瘦素浓度更高。在病态肥胖患者中,25(OH)D 与瘦素、抵抗素、脂联素、白细胞介素-18、可溶性肿瘤坏死因子受体 1 和 2 或 C-反应蛋白均无相关性。在病态肥胖患者中,25(OH)D 状态与脂联素和炎症细胞因子的浓度无差异。25(OH)D 与血糖和胰岛素抵抗或血脂谱之间也没有关联。血浆 25(OH)D 浓度与肥胖标志物相关,但与炎症相关的脂肪细胞因子无关。这种缺乏关联不支持 25(OH)D 在病态肥胖患者中观察到的促炎环境中发挥主要作用。此外,维生素 D 缺乏症患者的炎症状态并没有更大。